Syntagon Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8


  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Syntagon General Information


Manufacturer and developer of drugs and chemicals. The company involved in contract development and manufacturing organization (CDMO) and testing pharmaceutical ingredients supporting clinical trials and launched products.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Box 2073
  • 151 02 Sodertalje
  • Sweden
+46 08-554 000 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syntagon Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Syntagon‘s full profile, request access.

Request a free trial

Syntagon Executive Team (2)

Name Title Board Seat Contact Info
Paul Alhadeff Co-Founder & General Manager
You’re viewing 1 of 2 executive team members. Get the full list »

Syntagon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Syntagon FAQs

  • When was Syntagon founded?

    Syntagon was founded in 1998.

  • Who is the founder of Syntagon?

    Michael Lofthagen and Paul Alhadeff are the founders of Syntagon.

  • Where is Syntagon headquartered?

    Syntagon is headquartered in Sodertalje, Sweden.

  • What is the size of Syntagon?

    Syntagon has 8 total employees.

  • What industry is Syntagon in?

    Syntagon’s primary industry is Drug Discovery.

  • Is Syntagon a private or public company?

    Syntagon is a Private company.

  • What is Syntagon’s current revenue?

    The current revenue for Syntagon is 00000.

  • When was Syntagon acquired?

    Syntagon was acquired on 08-May-2018.

  • Who acquired Syntagon?

    Syntagon was acquired by Ardena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »